Phu V Tran1, Bruce C Kennedy2, Marc T Pisansky2, Kyoung-Jae Won3, Jonathan C Gewirtz4, Rebecca A Simmons5, Michael K Georgieff6. 1. Department of Pediatrics, tranx271@umn.edu. 2. Graduate Program in Neuroscience, and. 3. Institute for Diabetes, Obesity and Metabolism, Department of Genetics, and. 4. Graduate Program in Neuroscience, and Department of Psychology, University of Minnesota, Minneapolis, MN; 5. Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA. 6. Department of Pediatrics, Graduate Program in Neuroscience, and.
Abstract
BACKGROUND: Early-life iron deficiency is a common nutrient deficiency worldwide. Maternal iron deficiency increases the risk of schizophrenia and autism in the offspring. Postnatal iron deficiency in young children results in cognitive and socioemotional abnormalities in adulthood despite iron treatment. The rat model of diet-induced fetal-neonatal iron deficiency recapitulates the observed neurobehavioral deficits. OBJECTIVES: We sought to establish molecular underpinnings for the persistent psychopathologic effects of early-life iron deficiency by determining whether it permanently reprograms the hippocampal transcriptome. We also assessed the effects of maternal dietary choline supplementation on the offspring's hippocampal transcriptome to identify pathways through which choline mitigates the emergence of long-term cognitive deficits. METHODS: Male rat pups were made iron deficient (ID) by providing pregnant and nursing dams an ID diet (4 g Fe/kg) from gestational day (G) 2 through postnatal day (PND) 7 and an iron-sufficient (IS) diet (200 g Fe/kg) thereafter. Control pups were provided IS diet throughout. Choline (5 g/kg) was given to half the pregnant dams in each group from G11 to G18. PND65 hippocampal transcriptomes were assayed by next generation sequencing (NGS) and analyzed with the use of knowledge-based Ingenuity Pathway Analysis. Real-time polymerase chain reaction was performed to validate a subset of altered genes. RESULTS: Formerly ID rats had altered hippocampal expression of 619 from >10,000 gene loci sequenced by NGS, many of which map onto molecular networks implicated in psychological disorders, including anxiety, autism, and schizophrenia. There were significant interactions between iron status and prenatal choline treatment in influencing gene expression. Choline supplementation reduced the effects of iron deficiency, including those on gene networks associated with autism and schizophrenia. CONCLUSIONS: Fetal-neonatal iron deficiency reprograms molecular networks associated with the pathogenesis of neurologic and psychological disorders in adult rats. The positive response to prenatal choline represents a potential adjunctive therapeutic supplement to the high-risk group.
BACKGROUND: Early-life iron deficiency is a common nutrient deficiency worldwide. Maternal iron deficiency increases the risk of schizophrenia and autism in the offspring. Postnatal iron deficiency in young children results in cognitive and socioemotional abnormalities in adulthood despite iron treatment. The rat model of diet-induced fetal-neonatal iron deficiency recapitulates the observed neurobehavioral deficits. OBJECTIVES: We sought to establish molecular underpinnings for the persistent psychopathologic effects of early-life iron deficiency by determining whether it permanently reprograms the hippocampal transcriptome. We also assessed the effects of maternal dietary choline supplementation on the offspring's hippocampal transcriptome to identify pathways through which choline mitigates the emergence of long-term cognitive deficits. METHODS: Male rat pups were made iron deficient (ID) by providing pregnant and nursing dams an ID diet (4 g Fe/kg) from gestational day (G) 2 through postnatal day (PND) 7 and an iron-sufficient (IS) diet (200 g Fe/kg) thereafter. Control pups were provided IS diet throughout. Choline (5 g/kg) was given to half the pregnant dams in each group from G11 to G18. PND65 hippocampal transcriptomes were assayed by next generation sequencing (NGS) and analyzed with the use of knowledge-based Ingenuity Pathway Analysis. Real-time polymerase chain reaction was performed to validate a subset of altered genes. RESULTS: Formerly ID rats had altered hippocampal expression of 619 from >10,000 gene loci sequenced by NGS, many of which map onto molecular networks implicated in psychological disorders, including anxiety, autism, and schizophrenia. There were significant interactions between iron status and prenatal choline treatment in influencing gene expression. Choline supplementation reduced the effects of iron deficiency, including those on gene networks associated with autism and schizophrenia. CONCLUSIONS:Fetal-neonatal iron deficiency reprograms molecular networks associated with the pathogenesis of neurologic and psychological disorders in adult rats. The positive response to prenatal choline represents a potential adjunctive therapeutic supplement to the high-risk group.
Authors: Katyarina E Brunette; Phu V Tran; Jane D Wobken; Erik S Carlson; Michael K Georgieff Journal: Dev Neurosci Date: 2010-08-06 Impact factor: 2.984
Authors: Erik S Carlson; Ivan Tkac; Rhamy Magid; Michael B O'Connor; Nancy C Andrews; Timothy Schallert; Hiromi Gunshin; Michael K Georgieff; Anna Petryk Journal: J Nutr Date: 2009-02-11 Impact factor: 4.798
Authors: Sarah J E Wong-Goodrich; Tiffany J Mellott; Melissa J Glenn; Jan K Blusztajn; Christina L Williams Journal: Neurobiol Dis Date: 2008-02-16 Impact factor: 5.996
Authors: Phu V Tran; Srikanth Dakoji; Kathryn H Reise; Kathleen K Storey; Michael K Georgieff Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-10-02 Impact factor: 3.619
Authors: T G M van Erp; D P Hibar; J M Rasmussen; D C Glahn; G D Pearlson; O A Andreassen; I Agartz; L T Westlye; U K Haukvik; A M Dale; I Melle; C B Hartberg; O Gruber; B Kraemer; D Zilles; G Donohoe; S Kelly; C McDonald; D W Morris; D M Cannon; A Corvin; M W J Machielsen; L Koenders; L de Haan; D J Veltman; T D Satterthwaite; D H Wolf; R C Gur; R E Gur; S G Potkin; D H Mathalon; B A Mueller; A Preda; F Macciardi; S Ehrlich; E Walton; J Hass; V D Calhoun; H J Bockholt; S R Sponheim; J M Shoemaker; N E M van Haren; H E H Pol; R A Ophoff; R S Kahn; R Roiz-Santiañez; B Crespo-Facorro; L Wang; K I Alpert; E G Jönsson; R Dimitrova; C Bois; H C Whalley; A M McIntosh; S M Lawrie; R Hashimoto; P M Thompson; J A Turner Journal: Mol Psychiatry Date: 2015-08-18 Impact factor: 15.992
Authors: Amanda Barks; Montana M Beeson; Timothy C Hallstrom; Michael K Georgieff; Phu V Tran Journal: Dev Neurosci Date: 2022-01-11 Impact factor: 2.984
Authors: Thomas W Bastian; William C von Hohenberg; Olivia R Kaus; Lorene M Lanier; Michael K Georgieff Journal: J Nutr Date: 2022-03-03 Impact factor: 4.798
Authors: Tiffany J Mellott; Olivia M Huleatt; Bethany N Shade; Sarah M Pender; Yi B Liu; Barbara E Slack; Jan K Blusztajn Journal: PLoS One Date: 2017-01-19 Impact factor: 3.240